Biotech · Private company
IMMUNOe Research Centers
Track this companyFree. Adds IMMUNOe Research Centers to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- RuconestPhase 2 · Post-Viral Fatigue SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- C1-esterase inhibitor [recombinant] (C1-INH-R)CVI - Common Variable ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- IVIGPediatric Acute-Onset Neuropsychiatric SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 InfectionPHASE2 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04705831 · fetched Nov 12, 2026
- A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG InfusionsPHASE4 · COMPLETED · started Jun 13, 2018ClinicalTrials.gov NCT03576469 · fetched Nov 12, 2026
- A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)PHASE4 · UNKNOWN · started Nov 24, 2017ClinicalTrials.gov NCT03348618 · fetched Nov 12, 2026